FAM110B and pancreatic adenocarcinoma: Herein, we found that the expression of FAM110B was decreased along with the tumor differentiation grades, which showed that FAM110B was negatively associated with tumor differentiation and could be served as diagnosis and survival marker of pancreatic adenocarcinoma.